Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Myriad Genetics Inc (NASDAQ:MYGN)

During the Trading Day
34.12 -0.51 / -1.47%
As of 4:00pm ET
Day’s Change
During After-Hours   Switch to standard view »
34.12 0.00 / 0.00%
 
Volume: 226.1K

Today’s Trading

Previous close34.63
Today’s open34.08
Day’s range33.89 - 34.57
Volume1,060,588
Average volume (3 months)940,486
Market cap$2.5B
Dividend yield--
Data as of 4:00pm ET, 02/11/2016

Growth & Valuation

Earnings growth (last year)-52.00%
Earnings growth (this year)+13.96%
Earnings growth (next 5 years)+15.70%
Revenue growth (last year)-7.08%
P/E ratio25.7
Price/Sales3.50
Price/Book3.60

Competitors

 Today’s
change
Today’s
% change
HZNPHorizon Pharma PLC-0.16-0.98%
ICPTIntercept Pharmaceut...-1.45-1.51%
IPXLImpax Laboratories I...-1.45-4.51%
AKRXAkorn Inc-1.57-6.48%
Data as of 4:00pm ET, 02/11/2016

Financials

Next reporting dateMay 3, 2016
EPS forecast (this quarter)$0.38
Annual revenue (last year)$723.1M
Annual profit (last year)$80.2M
Net profit margin11.09%

Profile

Sector
Health Technology
Industry
Biotechnology
President &
Chief Executive Officer
Mark C. Capone
Executive Vice President-
International Operations
Gary A. King
Corporate headquarters
Salt Lake City, Utah

Forecasts

Partner Offers